Clinuvel Pharmaceuticals Limited (ASX:CUV)
10.40
-0.15 (-1.42%)
Jun 5, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 520.10 million as of June 5, 2025. Its market cap has decreased by -33.31% in one year.
Market Cap
520.10M
Enterprise Value
322.60M
Revenue
91.02M
Ranking
n/a
PE Ratio
13.52
Stock Price
10.40
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 520.10M, an increase of 9,852.83%. That is a compound annual growth rate of 20.82%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 119.22B |
Pro Medicus | 29.60B |
Cochlear | 17.65B |
Sonic Healthcare | 12.77B |
Telix Pharmaceuticals | 9.20B |
Ramsay Health Care | 8.83B |
Ansell | 4.56B |
Regis Healthcare | 2.40B |